Archives

by in
Entry Author Date Location
Ariad Brings Third Cancer Drug Into Human Trials 09/22/11 Boston
J&J Honors Genentech Scientist, Holds Meeting on Future of Anti-Angiogenesis Drugs 09/15/11 New York
Aura Biosciences Raises $4.5M to Advance Nano-Drug Weapon Against Cancer 09/08/11 Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial 09/06/11 Boston
Delcath Takes FDA Hassle in Stride, Prepares to Sell New Chemo Device Overseas 08/17/11 New York
NYC’s Coronado Biosciences Plans Two Drug Trials, Wall Street Debut, and Boston Move 07/21/11 Boston
Veterans of J&J, Pfizer, and Medimmune Seek to Transform Arno into Oncology Powerhouse 07/19/11 New York
Amag Eyes Rebound, Idera Surges On Despite Merck KGaA Drop, Verastem Snags $32M, & More Boston-Area Life Sciences News 07/15/11 Boston
Sanofi Collaboration Drives Regeneron’s Transformation From R&D House to Commercial Player 07/13/11 New York
PTC Teams With AstraZeneca 06/29/11 New York
Curis and Genentech Unleash the Hedgehog to Fight a Deadly Skin Cancer 06/28/11 Boston
Constellation Pharma Raises More Money and Further Defines Pipeline 06/17/11 Boston
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model 06/08/11 New York
New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters 06/01/11 New York
Cyclacel Looks to ASCO as Showcase for Potent Cancer-Fighting Cocktail 05/31/11 New York
Aveo Forms $15 Million Cancer Deal With J&J Unit 05/31/11 Boston
Pfizer Lung Cancer Drug to Get Priority Review 05/17/11 New York
FDA Panel OKs Vertex Drug, Dyax Works With FivePrime, Genzyme Amends Anika Lawsuit, & More Boston-Area Life Sciences News 04/29/11 Boston
New Oncology R&D House H3 Biomedicine Launches in Cambridge, With Eisai Support 01/28/11 Boston
Molecular Insight Announces Ch. 11, Restructuring 12/10/10 Boston
Anchor Therapeutics Hooks Deal Worth Up to $480M with J&J 09/09/10 Boston
Mercator Therapeutics Embarks on Journey to Develop Targeted Cancer Drugs 09/01/10 Boston
Aileron Inks Deal with Roche, Worth Up to $1.1B, to Develop Stapled Peptide Drugs 08/24/10 Boston
Conatus Gets Pfizer Subsidiary 08/02/10 San Diego
How Microsoft (and Startups) Can Make Money in Health IT, Personalized Medicine Is a “Crock,” and Other Highlights from the Xconomy Forum 05/14/10 Seattle
Epizyme Entices Broad Institute Player, Robert Gould, to Take Over as CEO 03/24/10 Boston
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data 05/15/09 Boston
Cell Therapeutics, Spectrum Form Joint Venture 11/26/08 Seattle
Page 2 of 2 « previous page

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.